WALKER NEAL (President and CEO) exercised options at ACLARIS THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/5/2026ACC: 0001604457-26-000003
DirectorOfficer· President and CEO
Since Dec 2018
-9.95K
Net shares
Net seller
$28.7K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
29.15K acquired · 39.10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+29.15K
Price / share
—
Trade value
—
% of position
2.0%
1/2/2026
1.48M→1.51M
Common Stock
Direct
Shares
−9.95K
Price / share
$2.88
Trade value
$28.66K
% of position
0.7%
1/2/2026
1.51M→1.50M
Total
Net shares
+19.20K
Net value
-$28.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | M · Option Exercise | +29.15K | — | — | 2.0% | 1.48M | 1.51M |
| Common Stock Direct | 1/2/2026 | F · Tax Withholding | −9.95K | $2.88 | $28.66K | 0.7% | 1.51M | 1.50M |
| Total | +19.20K | -$28.66K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
29.15K shares
Shares
−29.15K
Strike price
Held after
30.03K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock29.15K shares | 1/2/2026 | M · Option Exercise | −29.15K | — | 30.03K |